Treatment of lymphoma with rituximab and chemotherapy during pregnancy

References

• American Cancer Society. Cancer center statistics. DevCan version 6.7.8., National Cancer Institute; 2020. https://cancerstatisticscenter.cancer.org/#!/cancer-site/Non-Hodgkin%20lymphoma
   Google Scholar
• Chihara D, Nastoupil LJ, Williams JN, et al. New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy. Expert Rev Anticancer Ther. 2015;15(5):531–544.
   PubMed Web of Science ®Google Scholar
• Jaglowski SM, Linden E, Termuhlen AM, et al. Lymphoma in adolescents and young adults. Semin Oncol. 2009;36(5):381–418.
   PubMed Web of Science ®Google Scholar
• Salles G, Barrett M, Foà R, et al. Rituximab in B-Cell hematologic malignancies: a review of 20 years of clinical experience. Adv Ther. 2017;34(10):2232–2273.
   PubMed Web of Science ®Google Scholar
• Hoelzer D, Walewski J, Döhner H, German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia, et al. Improved outcome of adult burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood. 2014;124(26):3870–3879.
   PubMed Web of Science ®Google Scholar
• Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235–242.
   PubMed Web of Science ®Google Scholar
• Azim HA, Jr, Azim H, Peccatori FA. Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge. Expert Rev Clin Immunol. 2010;6(6):821–826.
   PubMed Web of Science ®Google Scholar
• Evens AM, Advani R, Press OW, et al. Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis. J Clin Oncol. 2013;31(32):4132–4139.
   PubMed Web of Science ®Google Scholar
• Sorosky JI, Sood AK, Buekers TE. The use of chemotherapeutic agents during pregnancy. Obstet Gynecol Clin North Am. 1997;24(3):591–599.
   PubMed Web of Science ®Google Scholar
• Peccatori FA, Azim HA, Jr, Orecchia R, ESMO Guidelines Working Group, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi160–vi170.
   PubMed Web of Science ®Google Scholar
• Lishner M, Avivi I, Apperley JF, et al. Hematologic malignancies in pregnancy: management guidelines from an international consensus meeting. J Clin Oncol. 2016;34(5):501–508.
   PubMed Web of Science ®Google Scholar
• Anusim N, Ionescu F, Afolayan-Oloye O, et al. Diffuse large B-cell lymphoma of the vagina in pregnancy. BMJ Case Rep. 2020;13(1):e233145.
   PubMedGoogle Scholar
• Hashimoto Y, Omura H, Tokuyasu Y, et al. Successful management of primary mediastinal large B-cell lymphoma during pregnancy. Intern Med. 2019;58(23):3455–3459.
   PubMed Web of Science ®Google Scholar
• Khalid S, Khalid A, Daw H, et al. Management of primary mediastinal B-Cell lymphoma in pregnancy. Cureus. 2018;10(2):e2215.
   PubMed Web of Science ®Google Scholar
• Lee EJ, Ahn KH, Hong SC, et al. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth. Obstet Gynecol Sci. 2014;57(6):526–529.
   PubMedGoogle Scholar
• Mandal PK, Dolai TK, Bagchi B, et al. B cell suppression in newborn following treatment of pregnant diffuse large B-cell lymphoma patient with rituximab containing regimen. Indian J Pediatr. 2014;81(10):1092–1094.
   PubMed Web of Science ®Google Scholar
• Perez CA, Amin J, Aguina LM, et al. Primary mediastinal large B-Cell lymphoma during pregnancy. Case Rep Hematol. 2012;2012:197347.
   PubMedGoogle Scholar
• Rey J, Coso D, Roger V, et al. Rituximab combined with chemotherapy for lymphoma during pregnancy. Leuk Res. 2009;33(3):e8–e9.
   PubMedGoogle Scholar
• Friedrichs B, Tiemann M, Salwender H, et al. The effects of rituximab treatment during pregnancy on a neonate. Haematologica. 2006;91(10):1426–1427.
   PubMed Web of Science ®Google Scholar
• Decker M, Rothermundt C, Holländer G, et al. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol. 2006;7(8):693–694.
   PubMed Web of Science ®Google Scholar
• Herold M, Schnohr S, Bittrich H. Efficacy and safety of a combined rituximab chemotherapy during pregnancy. J Clin Oncol. 2001;19(14):3439.
   PubMed Web of Science ®Google Scholar
• Magloire LK, Pettker CM, Buhimschi CS, et al. Burkitt's lymphoma of the ovary in pregnancy. Obstet Gynecol. 2006;108(3 Pt 2):743–745.
   PubMed Web of Science ®Google Scholar
• Peterson C, Lester DR, Jr, Sanger W. Burkitt's lymphoma in early pregnancy. J Clin Oncol. 2010;28(9):e136–e138.
   PubMed Web of Science ®Google Scholar
• Brooks T, Weale N, Neuberger F, et al. The multidisciplinary care of a woman presenting with lymphoma in pregnancy whose delivery was also complicated by placenta accreta spectrum. Obstet Med. 2021;14(1):50–52.
   PubMed Web of Science ®Google Scholar
• Mittel RJ, Tobin MC, Kulik J. Neonatal B-cell suppression after in utero exposure to R-CHOP. Ann Allergy Asthma Immunol. 2013;111(3):221–222.
   PubMed Web of Science ®Google Scholar
• Fiascone S, Datkhaeva I, Winer ES, et al. Primary mediastinal large B-cell lymphoma in pregnancy. Leuk Lymphoma. 2016;57(1):240–243.
   PubMed Web of Science ®Google Scholar
• Padberg S, Mick I, Frenzel C, et al. Transient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancy. Reprod Toxicol. 2017;71:146–149.
   PubMed Web of Science ®Google Scholar
• Rajendra A, Devasia AJ, Francis NR, et al. Antenatal chemotherapy in a case of diffuse large B-cell lymphoma. BMJ Case Rep. 2018;2018:bcr2017222992.
   PubMedGoogle Scholar
• Cordeiro A, Machado AI, Borges A, et al. Burkitt's lymphoma related to Epstein-Barr virus infection during pregnancy. Arch Gynecol Obstet. 2009;280(2):297–300.
   PubMed Web of Science ®Google Scholar
• Agarwal N, Watt-Coote I. A case of B-cell lymphoma in a pregnant woman presenting with superior vena cava obstruction. Obstet Med. 2012;5(4):176–177.
   PubMedGoogle Scholar
• Pinnix CC, Andraos TY, Milgrom S, et al. The management of lymphoma in the setting of pregnancy. Curr Hematol Malig Rep. 2017;12(3):251–256.
   PubMed Web of Science ®Google Scholar
• Chakravarty EF, Murray ER, Kelman A, et al. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117(5):1499–1506.
   PubMed Web of Science ®Google Scholar
• Avilés A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001;2(3):173–177.
   PubMedGoogle Scholar
• Maggen C, Dierickx D, Cardonick E, et al.; International Network on Cancer Infertility Pregnancy (INCIP). Maternal and neonatal outcomes in 80 patients diagnosed with non-Hodgkin lymphoma during pregnancy: results from the international network of cancer, infertility and pregnancy. Br J Haematol. 2021;193(1):52–62.
   PubMed Web of Science ®Google Scholar
• McMillan AK, Phillips EH, Kirkwood AA, et al. Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial. Ann Oncol. 2020;31(9):1251–1259.
   PubMed Web of Science ®Google Scholar
• Testa AC, De Blasis I, Di Legge A, et al. Burkitt's lymphoma of the breast metastatic to the ovary diagnosed during pregnancy. Ultrasound Obstet Gynecol. 2013;42(3):364–366.
   PubMed Web of Science ®Google Scholar
• Burnette BL, Jentoft MA, Porrata LF, et al. Single-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive management. J Clin Oncol. 2014;32(7):e14–e17.
   PubMed Web of Science ®Google Scholar
• Pereg D, Koren G, Lishner M. The treatment of hodgkin's and non-Hodgkin's lymphoma in pregnancy. Haematologica. 2007;92(9):1230–1237.
   PubMed Web of Science ®Google Scholar